NCT05806554View on ClinicalTrials.gov

Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

June 13, 2024

Study Completion Date

October 22, 2024

Conditions
Diabetes Mellitus
Interventions
DEVICE

Continuous glucose monitoring device

Continuous glucose monitoring device

Trial Locations (3)

30318

Atlanta Diabetes Associates, Atlanta

94598

Diablo Clinical Research, Walnut Creek

98057

Rainier Clinical Research Center, Renton

Sponsors
All Listed Sponsors
collaborator

Integrated Medical Development

INDUSTRY

lead

Sinocare

INDUSTRY